Publication | Closed Access

Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats

HepatologyLiver Cirrhosis RatsLiver PhysiologyPortal HypertensionPhysiologyGastroenterologyHepatitisPathologyHepatotoxicityLiver DiseaseMedicineCell SignalingPartial Portal HypertensiveDrug-induced Liver InjuryHealth Sciences